Old metrics no longer reveal how influential research truly is in an AI-driven world, where knowledge is consumed without ...

Researchers used mass spectrometry to map the molecular composition of fetal bovine serum, identifying a core proteome ...

Seasoned life sciences executive brings extensive global commercial leadership to accelerate growth and expand adoption of Seer’s Proteograph® ...

Dr. Marco A. M. Prado is a distinguished neuroscientist and Tier 1 Canada Research Chair in Neurochemistry of Dementia. His ...

Engineers at Rice University in the U.S. have developed a new room-temperature multiferroic material ...

Prometheus Program’ seeks to restore scientific integrity with dozens of policy recommendations, but some question role of ...

From decoding brain activity to automating neuroimaging analysis, AI is reshaping neuroscience research. Purpose-built tools merge large language models, automated data pipelines, and reproducibility ...

Frederik Huhn and Dr. Katharina Haft discuss how digital non‑contact dispensing is enabling miniaturized, sustainable liquid ...

Potency assay development uses DoE and QbD to improve accuracy, consistency, and regulatory readiness in biologics testing.

A decade ago, the National Institutes of Health (NIH) began requiring scientists to "consider sex as a biological variable" ...

Pancreatic cancer remains one of the most difficult cancers to treat, in large part because tumors do not exist in isolation.

From liver health to diabetes research, validated biomarker assays like FGF21 and GLP-1 ELISAs are reshaping how we detect and monitor metabolic conditions. These tests must undergo rigorous precision ...